InSite Vision, Alameda, Calif.-based ophthalmological products company, has announced that it will be presenting five sponsored posters at the Association for Research in Vision and Ophthalmology 2013 Annual Meeting.
The five posters will cover clinical data on the company's DuraSite 2 platform and treatment of various ophthalmologic conditions.
The ARVO 2013 meeting will be held May 5 to 9 in Seattle.
More Articles on Ophthalmology:
FDA Grants R-Tech Ueno IND Approval for Dry Eye Treatment
Pharm-Olam, InSite Vision Complete Phase 3 Clinical Study
Glaucoma Management Lens to be Presented at ARVO 2013
The five posters will cover clinical data on the company's DuraSite 2 platform and treatment of various ophthalmologic conditions.
The ARVO 2013 meeting will be held May 5 to 9 in Seattle.
More Articles on Ophthalmology:
FDA Grants R-Tech Ueno IND Approval for Dry Eye Treatment
Pharm-Olam, InSite Vision Complete Phase 3 Clinical Study
Glaucoma Management Lens to be Presented at ARVO 2013